Search

Your search keyword '"Kassai, Behrouz"' showing total 351 results
Start Over Author "Kassai, Behrouz"
351 results on '"Kassai, Behrouz"'

1. Preoperative 11C-Methionine PET-MRI in Pediatric Infratentorial Tumors

Author

Beuriat, Pierre-Aurélien, Flaus, Anthime, Portefaix, Aurélie, Szathmari, Alexandru, Janier, Marc, Hermier, Marc, Lorthois-Ninou, Sylvie, Scheiber, Christian, Isal, Sibel, Costes, Nicolas, Merida, Ines, Lancelot, Sophie, Vasiljevic, Alexandre, Leblond, Pierre, Faure Conter, Cécile, Saunier, Clarisse, Kassai, Behrouz, Vinchon, Matthieu, Di Rocco, Federico, and Mottolese, Carmine

Published
2024
Full Text
View/download PDF

8. Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children

Author

Pages, Nicolas, Bounabi, Anissa, Boussaha, Inesse, Ndiaye, Marietou, Portefaix, Aurélie, Simeon, Gaelle, Guy, Claire, Stagnara, Jean, Paret, Nathalie, Vial, Thierry, Eftekhari, Pirayeh, Floret, Daniel, Gajdos, Vincent, Langhendries, Jean-Paul, Bleyzac, Nathalie, Alberti, Corinne, Jacqz-Aigrain, Evelyne, Nguyen, Kim An, and Kassai, Behrouz

Published
2022
Full Text
View/download PDF

10. Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency ( SLC6A8 )

Author

Curie, Aurore, primary, Lion-François, Laurence, additional, Valayannopoulos, Vassili, additional, Perreton, Nathalie, additional, Gavanon, Marie, additional, Touil, Nathalie, additional, Brun-Laurisse, Amandine, additional, Gheurbi, Fahra, additional, Buchy, Marion, additional, Halep, Hulya, additional, Cheillan, David, additional, Mercier, Catherine, additional, Brassier, Anaïs, additional, Desnous, Béatrice, additional, Kassai, Behrouz, additional, De Lonlay, Pascale, additional, and Des Portes, Vincent, additional

Published
2024
Full Text
View/download PDF

12. High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study.

Author

Portefaix, Aurélie, Dhelens, Carole, Recher, Morgan, Cour-Andlauer, Fleur, Naudin, Jérôme, Mortamet, Guillaume, Joram, Nicolas, Tissières, Pierre, Ginhoux, Tiphanie, Kassai, Behrouz, Boutitie, Florent, Maucort-Boulch, Delphine, and Javouhey, Etienne

Subjects
TOXIC shock syndrome, MULTISYSTEM inflammatory syndrome in children, INTRAVENOUS immunoglobulins, SOFT tissue infections, BODY mass index, MEDICAL personnel
Published
2024
Full Text
View/download PDF

15. Collaboration between academics, small pharmaceutical company and patient organizations in the development of a new formulation of cysteamine in nephropathic cystinosis: A successful story

Author

Gaillard, Ségolène, Roche, Laurent, Deschênes, Georges, Morin, Denis, Vianey-Saban, Christine, Acquaviva-Bourdain, Cécile, Nony, Patrice, Subtil, Fabien, Mercier, Catherine, Cochat, Pierre, Bertholet-Thomas, Aurélia, Cornu, Catherine, and Kassai, Behrouz

Published
2020
Full Text
View/download PDF

17. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

Author

Campion, Dominique, Dartigues, Jean-Francois, Deleuze, Jean-François, Genin, Emmanuelle, Lambert, Jean-Charles, Redon, Richard, Allain-Launay, Emma, Bader-Meunier, Brigitte, Belot, Alexandre, Bouayed, Kenza, Burtey, Stephane, Carbasse, Aurélia, Decramer, Stéphane, Despert, Véronique, Fain, Olivier, Fischbach, Michel, Flodrops, Hugues, Galeotti, Caroline, Hachulla, Eric, Hatchuel, Yves, Kleinmann, Jean-Francois, Kone-Paut, Isabelle, Lanteri, Aurélia, Lemelle, Irène, Maillard, Hélène, Maurier, François, Meinzer, Ulrich, Melki, Isabelle, Morell-Dubois, Sandrine, Pagnier, Anne, Piram, Maryam, Ranchin, Bruno, Reumaux, Héloise, Samaille, Charlotte, Sibilia, Jean, Weill, Olivia, Al-Abadi, Eslam, Armon, Kate, Bailey, Kathryn, Beresford, Michael, Brennan, Mary, Ciurtin, Coziana, Gardner-Medwin, Janet, Haslam, Kirsty, Hawley, Daniel, Leahy, Alice, Leone, Valentina, Mewar, Devesh, Moots, Rob, Pilkington, Clarissa, Ramanan, Athimalaipet, Rangaraj, Satyapal, Ratcliffe, Annie, Riley, Philip, Sen, Ethan, Sridhar, Arani, Wilkinson, Nick, Wood, Fiona, Rice, Gillian I, Omarjee, Sulliman Ommar, Rouchon, Quentin, Smith, Eve M D, Moreews, Marion, Tusseau, Maud, Frachette, Cécile, Bournhonesque, Raphael, Thielens, Nicole, Gaboriaud, Christine, Rouvet, Isabelle, Chopin, Emilie, Hoshino, Akihiro, Latour, Sylvain, Cimaz, Rolando, Romagnani, Paula, Malcus, Christophe, Fabien, Nicole, Sarda, Marie-Nathalie, Kassai, Behrouz, Lega, Jean-Christophe, Abou-Jaoude, Pauline, Bruce, Ian N, Simonet, Thomas, Bardel, Claire, Rollat-Farnier, Pierre Antoine, Viel, Sebastien, O'Sullivan, James, Walzer, Thierry, Mathieu, Anne-Laure, Marenne, Gaelle, Ludwig, Thomas, Ellingford, Jamie, Briggs, Tracy A, Beresford, Michael W, and Crow, Yanick J

Published
2020
Full Text
View/download PDF

18. Sécurité des agents biologiques dans les maladies rhumatismales pédiatriques : étude rétrospective multicentrique en situation réelle dans la base de données JIRcohorte

Author

Cabrera, Natalia, Lega, Jean-Christophe, Kassai, Behrouz, Wouters, Carine, Kondi, Anuela, Cannizzaro, Elvira, Woerner, Andreas, Chausset, Aurelie, Roethlisberger, Samuel, Jeanneret, Cyril, Aeschlimann, Florence, Malik, Salma, Duquesne, Agnès, Kaiser, Daniela, Higel, Laetitia, Maes, Anne, Berthet, Gerald, Hentgen, Veronique, Kone-Paut, Isabelle, Belot, Alexandre, and Hofer, Michael

Published
2020
Full Text
View/download PDF

19. Project Rebuild the Evidence Base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients.

Author

Boussageon, Rémy, primary, Blanchard, Clara, additional, Charuel, Elodie, additional, Menini, Thibault, additional, Pereira, Bruno, additional, naudet, florian, additional, Kassai, Behrouz, additional, Gueyffier, François, additional, Cucherat, Michel, additional, and Vaillant-Roussel, Hélène, additional

Published
2024
Full Text
View/download PDF

21. Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs

Author

Gaillard, Segolene, Roche, Laurent, Lemoine, Sandrine, Deschênes, Georges, Morin, Denis, Vianey-Saban, Christine, Acquaviva-Bourdain, Cécile, Ranchin, Bruno, Bacchetta, Justine, Kassai, Behrouz, Nony, Patrice, Bodénan, Eurielle, Laudy, Valérie, Rouges, Cécile, Zarrabian, Setareh, Subtil, Fabien, Mercier, Catherine, Cochat, Pierre, and Bertholet-Thomas, Aurélia

Published
2021
Full Text
View/download PDF

22. Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs

Author

Gaillard, Segolene, Roche, Laurent, Lemoine, Sandrine, Deschênes, Georges, Morin, Denis, Vianey-Saban, Christine, Acquaviva-Bourdain, Cécile, Ranchin, Bruno, Bacchetta, Justine, Kassai, Behrouz, Nony, Patrice, Bodenan, Eurielle, Laudy, Valerie, Rouges, Cecile, Zarrabian, Setareh, Subtil, Fabien, Mercier, Catherine, Cochat, Pierre, and Bertholet-Thomas, Aurelia

Subjects
Cysteamine -- Usage, Patient compliance -- Research, Drug utilization -- Methods, Kidney diseases -- Diagnosis -- Drug therapy, Pediatric research, Cystinosis -- Diagnosis -- Drug therapy, Health
Abstract

Introduction In nephropathic cystinosis (NC), adherence to cysteamine remains challenging; poor adherence is worsening the disease progression with a decline of kidney function and increase of extrarenal morbidities. Our objective was to describe adherence to cysteamine in NC patients, using electronic monitoring systems. Methods Patients with confirmed NC, aged > 4 years and receiving oral cysteamine (short acting or delayed release formulation as standard of care) from 3 French reference centers, were included. Adherence to treatment was primarily assessed as the percentage of days with a good adherence score, adherence score rating from 0 (poor) to 2 (good). A descriptive analysis was performed after 1-year follow-up. Results Seventeen patients (10 girls, median age: 13.9 (5.4-33.0) years) were included. Median age at diagnosis was 17.0 (3.0-76.9) months and age at start of cysteamine was 21.0 (15.5-116.3) months. Median daily dose of cysteamine was 1.05 (0.55-1.63) g/m.sup.2/day. Over the year, the median percentage of days with a good adherence score was 80 (1-99)% decreasing to 68 (1-99)% in patients > 11 years old. The median of average number of hours covered by treatment in a day was 22.5 (6.1-23.9) versus 14.9 (9.2-20.5) hours for delayed release versus short acting cysteamine. Conclusion Our data are the first describing a rather good adherence to cysteamine, decreasing in adolescents and adults. We described a potential interest of the delayed release formulation. Our data highlight the need for a multidisciplinary approach including therapeutic education and individualized approaches in NC patients transitioning to adulthood. Graphical abstract, Author(s): Segolene Gaillard [sup.1] [sup.2] , Laurent Roche [sup.2] [sup.4] , Sandrine Lemoine [sup.3] , Georges Deschênes [sup.5] , Denis Morin [sup.6] , Christine Vianey-Saban [sup.7] , Cécile Acquaviva-Bourdain [sup.7] [...]

Published
2020
Full Text
View/download PDF

23. Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme

Author

Ferry, Tristan, Le Bouar, Myrtille, Briot, Thomas, Roussel-Gaillard, Tiphaine, Perpoint, Thomas, Roux, Sandrine, Valour, Florent, Javaux, Clément, Wan, Marie, Conrad, Anne, Becker, Agathe, Triffault-Fillit, Claire, Simon, Marie, Braun, Evelyne, Van der Bogaart, Lorena, Chauvelot, Pierre, Bahuaud, Olivier, Landre, Sophie, Soueges, Sarah, Eberl, Isabelle, Dallosto, Karine, Boulant, Johanna, Marrocco, Nathalie, Ader, Florence, Lustig, Sébastien, Batailler, Cécile, Schmidt, Axel, Craighero, Fabien, Fleury, Andréa, El-Ameen, Ali, Schleef, Arnaud, Miailhes, Jade, Fustier, Anne, Himpens, Paul-Henri, Boussel, Loïc, Buisson, Marielle, Boussaha, Inesse, Kassai, Berhouz, Bouar, Myrtille Le, Kassai, Behrouz, and Ndiaye, Marietou

Published
2024
Full Text
View/download PDF

26. Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database

Author

Cabrera, Natalia, Lega, Jean-Christophe, Kassai, Behrouz, Wouters, Carine, Kondi, Anuela, Cannizzaro, Elvira, Woerner, Andreas, Chausset, Aurelie, Roethlisberger, Samuel, Jeanneret, Cyril, Aeschlimann, Florence, Malik, Salma, Duquesne, Agnès, Kaiser, Daniela, Higel, Laetitia, Maes, Anne, Berthet, Gerald, Hentgen, Veronique, Kone-Paut, Isabelle, Belot, Alexandre, and Hofer, Michael

Published
2019
Full Text
View/download PDF

27. Preoperative 11 C-Methionine PET-MRI in Pediatric Infratentorial Tumors.

Author

Beuriat, Pierre-Aurélien, Flaus, Anthime, Portefaix, Aurélie, Szathmari, Alexandru, Janier, Marc, Hermier, Marc, Lorthois-Ninou, Sylvie, Scheiber, Christian, Isal, Sibel, Costes, Nicolas, Merida, Ines, Lancelot, Sophie, Vasiljevic, Alexandre, Leblond, Pierre, Faure Conter, Cécile, Saunier, Clarisse, Kassai, Behrouz, Vinchon, Matthieu, Di Rocco, Federico, and Mottolese, Carmine

Published
2024
Full Text
View/download PDF

28. Phosphatidylserine enriched with polyunsaturated n‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial.

Author

Rheims, Sylvain, Herbillon, Vania, Gaillard, Ségolène, Mercier, Catherine, Villeuve, Nathalie, Villéga, Frédéric, Cances, Claude, Castelnau, Pierre, Napuri, Silvia, de Saint‐Martin, Anne, Auvin, Stéphane, Nguyen The Tich, Sylvie, Berquin, Patrick, de Bellecize, Julitta, Milh, Mathieu, Roy, Pascal, Arzimanoglou, Alexis, Bodennec, Jacques, Bezin, Laurent, and Kassai, Behrouz

Abstract

Background: Attention‐deficit hyperactivity disorder (ADHD) is a frequent comorbidity in children with epilepsy, which management mostly relies on the usual treatments of ADHD, especially methylphenidate. Supplementation with polyunsaturated n‐3 Fatty Acid (PUFA) has been proposed as an alternative therapeutic approach in ADHD without epilepsy but has never been evaluated in epilepsy‐associated ADHD. Methods: A multicenter double blind randomized placebo‐controlled trial evaluating supplementation with PUFA, in eicosapentaenoic‐ and docosahexaenoic‐acid form, conjugated to a phospholipid vector (PS‐Omega3) in children aged >6 and <16‐years old, and suffering from any type of epilepsy and ADHD (inattentive or combined type) according to DSM‐V. After a 4‐week baseline period, patients were allocated (1:1) either to placebo group or to PS‐Omega 3 group and entered a 12 week‐double‐blind treatment period which was followed by a 12 week‐open‐label treatment period. The primary outcome was the reduction of the ADHD‐rating scale IV attention‐deficit subscore after 12 weeks of treatment. Results: The study was stopped early because of lack of eligible participants and the expected sample size was not reached. Seventy‐four patients were randomized, 44 in PS‐Omega3, and 30 in the placebo group. The reduction after 12 weeks of treatment in the inattention subscore of the ADHD‐IV scale was −1.57 in the PS‐Omega3 group, and −2.90 in the placebo group (p = 0.33, α = 5%). Results were similar after 24 weeks of treatment and for all other ADHD‐related secondary outcomes, with no difference between placebo and PS‐Omega3. Conclusion: Our study remaining underpowered, no formal conclusion about the effect of Ps‐Omega3 could be drawn. However, our data strongly suggested that the PS‐Omega 3 formulation used in the current study did not improve ADHD symptoms in children with epilepsy. Plain Language Summary: Supplementation with polyunsaturated n‐3 Fatty Acid (PUFA) has been proposed in ADHD but has never been evaluated in patients with both epilepsy and ADHD. To address this issue, we conducted a multicenter double blind randomized placebo‐controlled trial evaluating supplementation with PUFA in children with epilepsy and ADHD. The study was stopped early because of lack of eligible participants, hampering formal conclusion. However, the evolution of the ADHD symptoms at 12 and 24 weeks did not differ between placebo and PUFA supplementation, strongly suggesting that PUFA did not improve ADHD symptoms in children with epilepsy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Familial and syndromic lupus share the same phenotype as other early-onset forms of lupus

Author

Weill, Olivia, Decramer, Stéphane, Malcus, Christophe, Kassai, Behrouz, Rouvet, Isabelle, Ginhoux, Tiphanie, Crow, Yanick J., Rieux-Laucat, Fredéric, Soulas-Sprauel, Pauline, Pagnier, Anne, Koné-Paut, Isabelle, Piram, Maryam, Galeotti, Caroline, Samaille, Charlotte, Reumaux, Héloïse, Lanteri, Aurélia, Dubois, Sandrine Morell, Lefebvre, Hélène, Burtey, Stéphane, Maurier, François, Carbasse, Aurélia, Lemelle, Irène, Meinzer, Ulrich, Despert, Véronique, Flodrops, Hugues, Fabien, Nicole, Ranchin, Bruno, Hachulla, Eric, Bader-Meunier, Brigitte, and Belot, Alexandre

Published
2017
Full Text
View/download PDF

32. Le phénotype des lupus familiaux ou syndromiques n’est pas différent des autres formes de lupus juvéniles

Author

Weill, Olivia, Decramer, Stéphane, Malcus, Christophe, Kassai, Behrouz, Rouvet, Isabelle, Ginhoux, Tiphanie, Crow, Yanick, Rieux-Laucat, Fredéric, Soulas-Sprauel, Pauline, Pagnier, Anne, Koné-Paut, Isabelle, Piram, Maryam, Galeotti, Caroline, Samaille, Charlotte, Reumaux, Héloïse, Lanteri, Aurélia, Dubois, Sandrine Morell, Lefebvre, Hélène, Burtey, Stéphane, Maurier, François, Carbasse, Aurélia, Lemelle, Irène, Meinzer, Ulrich, Despert, Véronique, Flodrops, Hugues, Fabien, Nicole, Ranchin, Bruno, Hachulla, Eric, Bader-Meunier, Brigitte, and Belot, Alexandre

Published
2017
Full Text
View/download PDF

33. The interplay between bone and vessels in pediatric CKD: lessons from a single-center study

Author

Preka, Evgenia, Ranchin, Bruno, Doyon, Anke, Vierge, Melody, Ginhoux, Tiphanie, Kassai, Behrouz, and Bacchetta, Justine

Subjects
Bone diseases -- Risk factors -- Research -- Care and treatment, Comorbidity -- Risk factors -- Care and treatment -- Research, Blood pressure -- Health aspects, Chronic kidney failure -- Care and treatment -- Diagnosis -- Development and progression -- Risk factors, CAT scans -- Usage, Health
Abstract

Objective Mineral and bone disorders associated to chronic kidney disease (CKD-MBD) are a daily challenge for pediatric nephrologists, with a significant risk of long-term bone and vascular comorbidities. Methods This single-center study is a prospective transversal evaluation of pediatric CKD patients of our center, part of the European 4C study. In addition to clinical and biochemical data, vascular and bone evaluation was performed: 24-h blood pressure assessment, carotid intima-media thickness (cIMT), pulse wave velocity (PWV), and high-resolution peripheral quantitative computed tomography (HR-pQCT) at the ultra-distal tibia. Results are presented as median (range). Results At a median age of 12.9 years (10.2-17.9), SDS height of - 1.0 (- 3.3-1.2) and estimated glomerular filtration rate (eGFR) of 33 mL/min/1.73m.sup.2 (11-72), 32 patients (8 girls) were evaluated. Median calcium, phosphate, parathyroid hormone (PTH), and 25 OHD3 levels were 2.44 mmol/L (2.24-2.78), 1.43 mmol/L (1.0-2.7), 80 pg/mL (9-359), and 70 nmol/L (32-116), respectively. Bivariate Spearman and backward multivariable analyses showed that calcium and bone trabecular thickness (Tb.Th), were positively associated with diastolic and mean arterial blood pressure (both for the 24 h, day and night assessment), whereas PTH and vitamin D did not predict blood pressure. Conclusions We show that the greater the serum levels of calcium, the greater the (diastolic and mean) blood pressure; moreover, the greater the Tb. Th, the greater the (diastolic and mean) blood pressure. The role of calcium supplements to explain such findings in early pediatric CKD can be discussed., Author(s): Evgenia Preka [sup.1] , Bruno Ranchin [sup.1] , Anke Doyon [sup.2] , Melody Vierge [sup.1] , Tiphanie Ginhoux [sup.3] , Behrouz Kassai [sup.3] [sup.4] [sup.5] [sup.6] , Justine Bacchetta [...]

Published
2018
Full Text
View/download PDF

37. Impaired Systolic and Diastolic Left Ventricular Function in Children with Chronic Kidney Disease - Results from the 4C Study

Author

Doyon, Anke, Haas, Pascal, Erdem, Sevcan, Ranchin, Bruno, Kassai, Behrouz, Mencarelli, Francesca, Lugani, Francesca, Harambat, Jerome, Matteucci, Maria Chiara, Chinali, Marcello, Habbig, Sandra, Zaloszyc, Ariane, Testa, Sara, Vidal, Enrico, Gimpel, Charlotte, Azukaitis, Karolis, Kovacevic, Alexander, Querfeld, Uwe, and Schaefer, Franz

Published
2019
Full Text
View/download PDF

38. Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial

Author

Kassai, Behrouz, Bouyé, Philippe, Gilbert-Dussardier, Brigitte, Godart, François, Thambo, Jean-Benoit, Rossi, Massimiliano, Cochat, Pierre, Chirossel, Pierre, Luong, Stephane, Serusclat, André, Canterino, Isabelle, Mercier, Catherine, Rabilloud, Muriel, Pivot, Christine, Pirot, Fabrice, Ginhoux, Tiphanie, Coopman, Stéphanie, Grenet, Guillaume, Gueyffier, François, Di-Fillippo, Sylvie, and Bertholet-Thomas, Aurélia

Published
2019
Full Text
View/download PDF

40. The French Version of the Autism-Spectrum Quotient in Adolescents: A Cross-Cultural Validation Study

Author

Sonie, Sandrine, Kassai, Behrouz, Pirat, Elodie, Bain, Paul, Robinson, Janine, Gomot, Marie, Barthelemy, Catherine, Charvet, Dorothee, Rochet, Thierry, Tatou, Moham, Assouline, Brigitte, Cabrol, Stephane, Chabane, Nadia, Arnaud, Valerie, Faure, Patricia, and Manificat, Sabine

Abstract

We assessed the accuracy of the French version of the "Autism Spectrum Quotient" ("AQ") in adolescents with Asperger syndrome (AS) and high-functioning autism (HFA) compared to healthy controls and adolescents with psychiatric disorders (PDs). Three groups of adolescents, aged 11-18, were assessed: 116 with AS/HFA (93 with IQ [greater than or equal to] 85 and 20 with 70 [less than or equal to] IQ less than 85), 39 with other PDs, and 199 healthy controls. The AS/HFA group scored significantly higher than the healthy control and PD groups. A cut-off score of 26 was used to differentiate the autism group from healthy controls with 0.89 sensitivity and 0.98 specificity. Scores did not vary by age or sex.

Published
2013
Full Text
View/download PDF

41. The Impact of COVID-19 on Maternal Mental Health during Pregnancy: A Comparison between Canada and China within the CONCEPTION Cohort

Author

Pagès, Nicolas, primary, Gorgui, Jessica, additional, Wang, Chongjian, additional, Wang, Xian, additional, Zhao, Jin-Ping, additional, Tchuente, Vanina, additional, Lacasse, Anaïs, additional, Côté, Sylvana, additional, King, Suzanne, additional, Muanda, Flory, additional, Mufike, Yves, additional, Boucoiran, Isabelle, additional, Nuyt, Anne Monique, additional, Quach, Caroline, additional, Ferreira, Ema, additional, Kaul, Padma, additional, Winquist, Brandace, additional, O’Donnell, Kieran J., additional, Eltonsy, Sherif, additional, Chateau, Dan, additional, Hanley, Gillian, additional, Oberlander, Tim, additional, Kassai, Behrouz, additional, Mainbourg, Sabine, additional, Bernatsky, Sasha, additional, Vinet, Évelyne, additional, Brodeur-Doucet, Annie, additional, Demers, Jackie, additional, Richebé, Philippe, additional, Zaphiratos, Valerie, additional, and Bérard, Anick, additional

Published
2022
Full Text
View/download PDF

43. Essais cliniques institutionnels : quel monitoring ?

Author

Cornu, Catherine, Binquet, Christine, Thalamas, Claire, Vigouroux, Céline, Gaillard, Ségolène, Ginhoux, Tiphanie, Vaz, Bernadette, Jossan, Claire, Félin, Alexandra, Sailly, Annabelle, Gueyffier, François, Journot, Valérie, and Kassaï, Behrouz

Published
2013
Full Text
View/download PDF

46. Version française des questionnaires de dépistage de l’autisme de haut niveau ou du syndrome d’Asperger chez l’adolescent : Quotient du spectre de l’autisme, Quotient d’empathie, et Quotient de systématisation. Protocole et traduction des questionnaires

Author

Sonié, Sandrine, Kassai, Behrouz, Pirat, Elodie, Masson, Sandrine, Bain, Paul, Robinson, Janine, Reboul, Anne, Wicker, Bruno, Chevallier, Coralie, Beaude-Chervet, Véronique, Deleage, Marie-Hélène, Charvet, Dorothée, Barthélémy, Catherine, Rochet, Thierry, Tatou, Mohamed, Arnaud, Valérie, and Manificat, Sabine

Published
2011
Full Text
View/download PDF

47. The COVID-19 Pandemic Impacted Maternal Mental Health Differently Depending on Pregnancy Status and Trimester of Gestation

Author

Bérard, Anick, primary, Gorgui, Jessica, additional, Tchuente, Vanina, additional, Lacasse, Anaïs, additional, Gomez, Yessica-Haydee, additional, Côté, Sylvana, additional, King, Suzanne, additional, Muanda, Flory, additional, Mufike, Yves, additional, Boucoiran, Isabelle, additional, Nuyt, Anne Monique, additional, Quach, Caroline, additional, Ferreira, Ema, additional, Kaul, Padma, additional, Winquist, Brandace, additional, O’Donnell, Kieran J., additional, Eltonsy, Sherif, additional, Chateau, Dan, additional, Zhao, Jin-Ping, additional, Hanley, Gillian, additional, Oberlander, Tim, additional, Kassai, Behrouz, additional, Mainbourg, Sabine, additional, Bernatsky, Sasha, additional, Vinet, Évelyne, additional, Brodeur-Doucet, Annie, additional, Demers, Jackie, additional, Richebé, Philippe, additional, and Zaphiratos, Valerie, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results